Home › NDC Lookup › RxCUI directory › RxCUI 1086786

Vilazodone hydrochloride 40 MG Oral Tablet [Viibryd] — RxCUI 1086786

RxNorm drug concept · Semantic branded drug
RxCUI 1086786 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1086786
Official nameVilazodone hydrochloride 40 MG Oral Tablet [Viibryd]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asViibryd 40 MG Oral Tablet
FDA products mapped3
Package NDCs mapped3
Reported Medicaid activity (SDUD)17,725 prescriptions · 26 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Vilazodone: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Vilazodone — brand name Viibryd — is an antidepressant approved to treat major depressive disorder (MDD) in adults. MDD is a clinical condition, not just ordinary sadness, and it c...
  • Yes, this one genuinely matters. If you take vilazodone without food, your body may absorb up to 50% less of the drug — which could make it significantly less effective. Try to tak...
  • Does it really matter if I take it with food?
  • The most common ones are digestive: diarrhea, nausea, and sometimes vomiting — especially in the first few weeks. Insomnia, headache, and dizziness are also possible. These often i...
📖 Read our full Vilazodone guide →

🕸️ Concept Web — How Vilazodone hydrochloride 40 MG Oral Tablet [Viib... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Vilazodone hydrochloride 40 MG Oral Tablet [Viibryd] RxCUI 1086786

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Vilazodone 1086769
    • Vilazodone hydrochloride 1086768
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Viibryd 1086773
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Vilazodone Oral Tablet 1086771
    • Vilazodone hydrochloride Oral Tablet 2647066
    • Vilazodone Oral Product 1164578
    • Vilazodone Pill 1164579
    • Vilazodone hydrochloride Oral Product 2662525
    • Vilazodone hydrochloride Pill 2663052
    • Vilazodone Oral Tablet [Viibryd] 1086775
    • Vilazodone hydrochloride Oral Tablet [Viibryd] 2655108
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Vilazodone hydrochloride 40 MG Oral Tablet SCD · 1086784
  • Vilazodone hydrochloride 40 MG SCDC · 1086783
  • Vilazodone Oral Tablet SCDF · 1086771
  • Vilazodone hydrochloride Oral Tablet SCDFP · 2647066
  • Vilazodone Oral Product SCDG · 1164578
  • Vilazodone Pill SCDG · 1164579
  • Vilazodone hydrochloride Oral Product SCDGP · 2662525
  • Vilazodone hydrochloride Pill SCDGP · 2663052

Brand-Name Concepts

  • Vilazodone hydrochloride 40 MG [Viibryd] SBDC · 1086785
  • Vilazodone Oral Tablet [Viibryd] SBDF · 1086775
  • Vilazodone hydrochloride Oral Tablet [Viibryd] SBDFP · 2655108
  • Viibryd Oral Product SBDG · 1186600
  • Viibryd Pill SBDG · 1186601
  • Viibryd BN · 1086773

📦 FDA Products & Package NDCs

3 products · 3 package NDCs
3 package NDCs map to RxCUI 1086786 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00456-1110-30 30 TABLET in 1 BOTTLE (0456-1110-30) VIIBRYD Allergan, Inc. 2011-04-29
00456-1120-30 30 TABLET in 1 BOTTLE (0456-1120-30) VIIBRYD Allergan, Inc. 2011-04-29
00456-1140-30 30 TABLET in 1 BOTTLE (0456-1140-30) VIIBRYD Allergan, Inc. 2011-04-29
Observed labelers: Allergan, Inc. (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.